|
|
Press Releases
| Tuesday, May 21, 2013 |
|
QuantuMDx and Genome Institute of Singapore announce collaboration to develop Asia-specific assays on QuantuMDx’s Q-POC™
|
|
A*STAR’s Genome Institute of Singapore (GIS) has signed an agreement with QuantuMDx (QMDx), a UK-based biotech developing handheld diagnostics and whole genome sequencing devices. Under this collaboration, QMDx’s wholly owned Singapore-based subsidiary QMDx Asia and GIS will develop Asia-specific point-of-care genetic tests for use with Q-POC™, QMDx’s handheld point-of-care device. QMDx will commercialize the tests. The first assay from the development pipeline will direct treatment of East Asian patients with kinase-driven cancers, such as chronic myeloid leukemia (CML) and epidermal growth factor receptor-mutated non-small lung cancer (EGFR NSCLC).
|
 |
|
|
|
|
| Monday, May 20, 2013 |
|
A better quality of life, thanks to the science of measurement
|
|
Whether you’re comparing the weight of the bak kwa you buy every Chinese New Year, following the doctor’s prescribed dose of medicine, or determining which light bulb conserves energy for your home, all these units of measurement you use regularly are results of metrology, the science of measurement. This year’s World Metrology Day, “Measurements in Daily Life”, celebrates metrology’s contribution to international trade and commerce, scientific advancement, and especially our everyday lives.
|
|
|
|
|
|
|
| Friday, May 17, 2013 |
|
A*STAR and Cytos bring Singapore's first influenza vaccine to clinical testing
|
|
Singapore’s Agency for Science, Technology and Research (A*STAR) and Switzerland’s Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos’ proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase 1 clinical trial, the safety and immunogenicity of this novel vaccine candidate and its potential to protect against H1N1 influenza infection will be evaluated.
|
|
|
|
|
|
|
| Wednesday, May 15, 2013 |
|
Singapore as Asia’s Innovation Capital
|
|
Singapore has received recognition in five global tracking studies in the area of Innovation and Research and Development (R&D). After 20 years of long term commitment to Science and Technology planning and investments, these indicators provide validation that Singapore is forging ahead towards becoming Asia’s Innovation Capital.
|
|
|
|
|
|
|
| Tuesday, May 14, 2013 |
|
A*STAR’S GET-UP Programme Marks 10 Years of Successful Partnership With SMES
|
|
Singapore, 14 May 2013—A*STAR’s Growing Enterprises through Technology Upgrade (GET-Up) programme today marked its 10-year milestone of strategic partnership with local Small and Medium Enterprises (SMEs) to upgrade their technological capabilities. Since its launch in 2003, the initiative has benefited over 400 companies across the electronic, infocomm, chemical, and biomedical science clusters.
|
|
|
|
|
|
|
| Monday, May 06, 2013 |
|
Shikino High-Tech kicks off R&D in Singapore with A*STAR Institute of Microelectronics
|
|
Singapore, 6 May 2013 – Shikino High-Tech Co., Ltd., a market leader in camera systems and image processing modules, with extensive experience in IP core licensing, has signed a research agreement with A*STAR Institute of Microelectronics (IME) to develop a low power and high performance Gyro-sensor ASIC IP block for commercial hand held applications.
|
|
|
|
|
|
|
|